Posted by Two Blokes
The U.S. Food and Drug Administration has approved Urogen Pharma's drug to treat a type of bladder cancer, the
Source: Two Blokes Trading
Posted by Two Blokes
Currency Exchange International, Corp. (OTCPK:CURN) Q2 2025 Earnings Conference Call June 12, 2025 8:30 AM ET
Source: Two Blokes Trading
Posted by Two Blokes
Pony AI stock plunges 29.5% in a month, but expansion plans, strong partners, and local supply chains hint at
Source: Two Blokes Trading
Posted by Two Blokes
Alphabet is strengthening its competitive position in the search and cloud with the infusion of AI amid challe
Source: Two Blokes Trading
Posted by Two Blokes
AFRM's merchant count hits 358K with strong GMV growth and global expansion fueling its BNPL momentum.
Source: Two Blokes Trading
Posted by Two Blokes
Talen's stock price is almost 5x higher than when it came out of bankruptcy in June 2023. The company benefits
Source: Two Blokes Trading
Posted by Two Blokes
Dan Deming is watching how market momentum is impacting individual stocks on today's Big 3. He sees Palo Alto
Source: Two Blokes Trading
Posted by Two Blokes
Under Armour (UAA) reported earnings 30 days ago. What's next for the stock?
Source: Two Blokes Trading
Posted by Two Blokes
Landstar (LSTR) reported earnings 30 days ago. What's next for the stock?
Source: Two Blokes Trading
Posted by Two Blokes
Fate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock?
Source: Two Blokes Trading
Posted by Two Blokes
Allogene Therapeutics (ALLO) reported earnings 30 days ago. What's next for the stock?
Source: Two Blokes Trading
Posted by Two Blokes
CyberArk (CYBR) reported earnings 30 days ago. What's next for the stock?
Source: Two Blokes Trading